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for refractory glaucoma in KuwaitAdel M. Aljazzaf, MD, FRCS a; Sidky M.A. Abdelmoaty, MD, FRCS a,⇑; Abdelmutalib H. Behbehani, MD, FRCS b;
Ahmad A. Abdulmuez, MD, FRCS a; Hadeel A. Aljazzaf, MD, FRCS cAbstractAim: To assess the outcomes and incidence of postoperative complications of Ahmad Glaucoma Valve implant in eyes with com-
plicated glaucoma performed in Kuwait.
Method: This is a retrospective study done at the Al-Bahar Eye Center in Kuwait. Charts of all patients who underwent Ahmad
Glaucoma Valve implant at the Al-Bahar Ophthalmic Center in Kuwait between 2006 and 2009 were reviewed. Surgical success
was defined as intraocular pressure less than 22 mmHg and greater than 5 mmHg without additional glaucoma surgery and with-
out loss of light perception.
Results: A total of 33 eyes from 30 patients with complicated glaucoma not responsive to conventional medical and non-implant
surgical treatment received Ahmad Glaucoma Valve implant. The success rate was 79% (26 cases). 20/26 (77%) cases of them
required antiglaucoma medications. The most common complication was encapsulated bleb (27%) and transient postoperative
hypotony was found in 19% of the cases.
Conclusion: Ahmad Glaucoma Valve implant appears to be effective and relatively safe for complicated glaucoma in Kuwait. The
success rate is comparable with those reported in other studies.
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Glaucoma drainage implants provide an alternative treat-
ment in complicated and refractory glaucoma cases,1,2 that
are resistant to medical therapy, laser treatment and glau-
coma filtration surgery.
These implants have a small caliber silicone tube that
drains aqueous from the anterior or posterior chamber to
an extrascleral device that maintains a fibrous pseudo-cyst
through which filtration can occur. Varieties of aqueous
shunting devices have been developed, including open-tubePeer review under responsibility
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erative period is a common complication associated with the
open-tube implants.3 Although valve implants may not com-
pletely close after initial perfusion with fluid, they do function
as flow-restricting devices.4 The Ahmad Glaucoma Valve
(AGV) implant (New World Medical, Inc., Rancho Cuca-
monga, California) directs aqueous flow through the silicone
tube and between two thin silicone elastomer membranes in
a tapered chamber. The initial clinical experience with this im-
plant indicated that hypotony and its attendant complica-
tions during the immediate postoperative period were lessProduction and hosting by Elsevier
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devices.5,6
Ahmad Glaucoma Valve was introduced in 1993, it has a
built in venture valve which offers resistance to the aqueous
outflow below about 7 mmHg helping to minimize postoper-
ative hypotony.7 However, the valve may be a potential site
for obstruction by inflammatory debris.8Aim
To assess the outcomes and incidence of postoperative
complications of AGV implant in eyes with complicated glau-
coma performed at the Al-Bahar Ophthalmic Center – Kuwait
between 2006 and 2009.Figure 1. Cumulative probability of success following Ahmed Glaucoma
Valve. Implantation was 79% at 1 year and 75% at 2 years (Kaplan–Meier
life table analysis).
Table 1. Characteristics of patients and preoperative diagnosis.
Number of patients 30
Number of eyes 33
Mean (range) age years 36.1 range (2–64)
Female:male 19:11
Mean (SD) follow up (months) 21.8 (9.2)
Types of glaucoma
No. of cases %
Neovascular glaucoma 14 42.4
Congenital glaucoma 4 12
Glaucoma with PKP 3 9.0
POAG with previous surgery 3 9.0
Chronic – angle closure-glaucoma 5 15
Uveitic glaucoma 3 9.0
ICE Syndrome 1 3.1Patients and methods
This is a retrospective study approved by the Al-Bahar Eye
Center Ethics Committee in Kuwait. This center serves as the
only referral tertiary eye center in Kuwait so that patients
attending this hospital are representative of various Kuwaiti
tribes and districts. Charts of all patients who were treated
with AGV at the Al-Bahar Ophthalmic Center in Kuwait be-
tween 2006 and 2009 were reviewed. Those patients were
not responsive to medical treatment, laser treatment or pre-
vious glaucoma surgery.
After informed written consent was obtained, the AGV
was implanted by one of three glaucoma subspecialty sur-
geons. Patients with neovascular glaucoma (NVG) were trea-
ted with PRP before the AGV was implemented when
feasible. For aphakic patients, anterior vitrectomy was per-
formed. The superotemporal quadrant was used for the im-
plant fixation in all eyes. Human donor pericardium was
used to cover the tube in all patients. No additional surgical
procedures were done at the same time of implant fixation
for any patient, post operative treatment consisted of topical
steroids and antibiotics.
Intraocular pressure was measured with a Goldman appla-
nation tonometer, a tonopen (Mentor O & O, Norwell, Mas-
sachusetts), or Perkins (Clement Clarke, Columbus, Ohio).
The tube of AGV was irrigated with balanced salt solution
to open the valve mechanism. After conjunctival incision and
separation of Tenon capsule from the sclera, the implant
plate was secured 8–10 mm posterior to the corneal limbus
with two interrupted 10-0 nylon. All the implants were in-
serted in the superotemporal quadrant. The tube was
trimmed to extend from 1 to 3 mm beyond the posterior sur-
gical limbus. A 23-gauge needle was used to enter the ante-
rior chamber at the surgical limbus parallel to the iris plane,
and the tube was inserted into the anterior chamber through
the needle track. The tube was loosely secured to the sclera
posterior to the limbus and then covered with pericardium
which was secured with interrupted 10-0 nylon. The conjunc-
tiva was closed with a 9-0 vicryl suture, and subconjunctival
injections of antibiotic and corticosteroids were administered
before the eye was patched. Postoperative treatment con-
sisted of topical corticosteroids and antibiotics.
Surgical success was defined as intraocular pressure less
than 22 mmHg and greater than 5 mmHg without additional
glaucoma surgery and without loss of light perception. Post-
operative use of antiglaucoma medications was not a
criterion of success or failure. The definition of hypotony inthis study was IOP of 5 mmHg or less in two consecutive
visits.
The cumulative probability of success was analyzed by the
Kaplan–Meier life-table analysis (Fig. 1).Results
A total of 33 eyes from 30 patients were included in the
study. The mean age of the patients was 36.1 years (range
2–64 yeas); the mean follow up period was 21.8 ± 9.2 months
(range 6–44 months). There were 19 females and 11 males
(Table 1). The preoperative diagnosis was, 14 cases (42.4%)
were Neovascular glaucoma with proliferative diabetic Reti-
nopathy, 4 cases (12%) were Congenital glaucoma, 3 cases
(9%) were glaucoma with penetrating keratoplasty, 3cases
(9%) were Primary open angle glaucoma with previous sur-
gery, 5 cases (15%) were chronic Angle closure glaucoma, 3
cases (9%) were Uveitic glaucoma, one case (3.1%) was ICE
syndrome (Table 1) and 18 cases (54.5%) were pseudophakic
at the time of surgery. Before AGV were implanted 20 cases
(60.6%) had ocular procedures including cataract extraction,
penetrating keratoplasty, trabeclectomy, trabeclotomy and
cyclophotocoagulation, and pan-retinal laser photocoagula-
tion. The mean pre-operative IOP was 37 ± 12.1 mmHg;
Figure 2. Scattergram of the preoperative versus the final intraocular pressure (IOP). The line of equivalence is also shown.
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one day, 18.7 mmHg after 3 months, and 18.0 mmHg after
1 year and to 19.5 mmHg after 2 years (Fig. 2). The mean
number of antiglaucoma medication pre-operatively was
3.1 which decreases to 1.1 postoperatively.
The success rate was 79% (26 cases). 20/26 (77%) cases of
them required antiglaucoma medications and the remaining
6/26 cases (23%) did not.
The final best corrected visual acuity improved by one
snellen line in only 3 cases (9%) and decreased by one line
in 9 cases (27%), the remaining 21 cases did not show change
in visual acuity (64%).
Postoperative complications occurred in 26 cases (78.8%).
Some eyes had more than one complication (Table 2).
Postoperative complications encountered in this study
were encapsulated bleb in 9 cases (27%), the mean time for
development of encapsulated bleb was 4.1 months, corneal
edema occurred in 5 cases (15%); two eyes of them devel-
oped corneal decompensation and needed Penetrating ker-
atoplasty (one in the PKP group and the other was in the
congenital glaucoma group) and Hyphema occurred in 6
cases (18%) especially within neovascular glaucoma group.
Shallow AC with hypotony occurred in 6 cases (18%) one
of these cases developed choroidal detachment which re-
solved spontaneously without any surgical intervention, 6
cases (18%) developed tube obstruction, Cataract developedTable 2. Postoperative complication.
No. of cases %
Encapsulated bleb 9 27
Corneal edema 5 15
Corneal decompensation 2 6
Hyphema 6 18
Shallow Ac and hypotony 6 18
Choroidal detachment 1 3
Cataract 2 6
Iritis 2 6
Tube obstruction 6 18
Post operative leakage 2 6
Erosion of graft 1 3
Vitreous hemorrhage 2 6in 2 cases (6%), and iritis developed in 2 cases (6%). The post-
operative leakage happened in 2 cases (6%) and this compli-
cation was secondary to short conjunctiva that needs further
management. Tube erosion occurred after 7 months in one
case (3%).
Two eyes (6%) developed vitreous hemorrhage, secondary
to progression of proliferative diabetic retinopathy, so these
cases were managed by vitrectomy and endolaser
photocoagulation.
Discussion
Glaucoma drainage implants have been used successfully
for the treatment of complicated glaucomas including NVG;
aphakic and pseudophakic glaucoma; glaucomas with multi-
ple filtering procedures; post penetrating keratoplasty glau-
coma; pediatric glaucoma; and uveitic glaucoma.1,2 One of
the common early postoperative complications is overdrai-
nage resulting in shallow AC, hypotony, and choroidal
detachment.3,9 There are various types of glaucoma drainage
implants available in the market. Some of them have a set
resistance mechanism to minimize over-drainage in the early
postoperative period. Those without set resistance mecha-
nism may require either a two staged procedure or ligature
technique. The AGV implant employs a built in Venturi valve
to provide resistance to aqueous flow.6
In our study, the AGV implant was able to decrease the
mean (SD) preoperative IOP from 37.0 ± 12.1 mmHg to
18.4 ± 10.7 mmHg at 3 months and 18.0 ± 14.1 mmHg at
1 year postoperatively. The success rate achieved was 79%.
Most case series reported success rates between 67% and
94%, depending on their criteria for success.3,11
The overall success rate in this study compares favorably
with the success rates of other glaucoma drainage devices.
The Baerveldt implant had a success rate of 72%,3 and the
Molteno implant showed 58–95% success rate,10 all of the
these glaucoma drainage implants divert aqueous from the
eye to the tenon space posterior to the limbus, which may ex-
plain similar success rates with different implants.
Hypotony and complications of hypotony are common
during the immediate postoperative period after nonvalved
glaucoma drainage implants. The most common complica-
18 A.M. Aljazzaf et al.tions after the Baerveldt implant were hypotony (32% of
eyes),3 in the current study, we found complications associ-
ated with hypotony in the immediate postoperative period
less frequently (18%). No eyes in our study required surgical
anterior chamber reformation.
Neovascular glaucoma was the most common preopera-
tive diagnosis (42.4%) in our series and it also carries the
highest failure rate in our study (54.5%). No other types of
glaucoma were found to have associated with such a high
failure rate in our series. It has been well shown that NVG is
associated with a much higher risk of failure than other types
of glaucoma.9–14
The most common medications used to lower postopera-
tive IOP in our series were topical latanoprost, topical car-
bonic anhydrase inhibitor and Alpha agonist.
The hypertensive phase reported to be as high as 20–40%
incidence in other implant series was not distinct in our series.
Although the mean IOP at 3 months was slightly higher than
that in 1 year, it might have been modified by the medica-
tions.11–15
Tube obstruction occurred in 6 cases (18%) it was due to
blood in 3 cases, iris or cornea in 2 cases and the last case
had presumed obstruction manifested by increases in intra-
ocular pressure during the first postoperative week, with an
apparently patent tube on slit lamp examination. The IOP re-
turned to normal spontaneously or with digital pressure in all
the cases. We did not observe any instances of tube occlu-
sion by the posterior capsule15 or irreversible valve mem-
brane adhesion16 which may be described in eyes with AGV
implants.
Conclusion
The Ahmad Glaucoma Valve implant appears to be effec-
tive and relatively safe for complicated glaucoma in Kuwait.
The success rate is comparable with those reported in other
studies. Hypotony is not commonly encountered with this im-
plant. Formation of encapsulated bleb is the most common
postoperative complication.References
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